Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

US Patent 9783596 · Granted Oct 10, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Development of dengue virus vaccine components2025
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2023
Development of dengue virus vaccine components2023
Development of dengue virus vaccine components2022
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural2022
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2020
Development of dengue virus vaccine components2020
Development of mutations useful for attenuating dengue viruses and chimeric deng2019
Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin2019
Development of dengue virus vaccine components2018
Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof2018
Monoclonal antibodies that neutralize anthrax toxins2018